Tin tức & Cập nhật

Increased intake of sugar-sweetened beverages (SSB) or artificially sweetened beverages (ASB) does not appear to contribute to the risk of dementia in older adults, according to a study.

Calcitonin gene-related peptide (CGRP) receptor blockade with erenumab does not appear to reduce the weekly frequency of cluster headache attacks, as shown in a study from Germany.

A wearable electroencephalograph (EEG) device that leverages artificial intelligence allows for precise, 12-to-24-h home monitoring of absence seizures, enabling rapid and tailored adjustments to antiseizure medication (ASM) and eliminating the need for further hospital admissions, as shown in an exploratory study.

Treatment with the investigational oral orexin receptor 2–selective agonist oveporexton appears to yield improvements in wakefulness, sleepiness, and cataplexy in individuals with narcolepsy type 1, according to the results of a phase II study.

Factors such as APOE4 allele, dementia onset before age 60 years, Alzheimer’s disease (AD) dementia subtype, worse cognition, stroke/transient ischaemic attack (TIA), and Parkinson’s disease (PD) all contribute to a heightened risk of late-onset epilepsy in people with cognitive decline, as reported in a study.

Fremanezumab appears to provide a two-for-one benefit in patients with migraine and comorbid depressive disorder, with data from the UNITE study showing that the drug helped reduce migraine days and lift mood.